Acknowledgments
Cancer
CANCER
We thank Genentech for providing funding and the study drug, ipatasertib, for NCT03853707, and the patients and their families for participating. The COH Biostatistics Core was supported by the National Cancer Institute of the National Institutes of Health (P30CA033572).